Public preview. Funding rounds, founders, and growth signals require a free account.

SELLAS Life Sciences Group, Inc. (SLS)

Late-stage clinical biopharmaceutical company developing novel cancer immunotherapies like galinpepimut-S and SLS009.[1][3]

GrowthBiotechNew York, NY

Total raised

$60.6M

Last round

Option

$18.4M · Mar 2024

Stage

Growth

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Free account unlocks 5 full profiles per day. Pro removes the limit.

Get notified the moment SELLAS Life Sciences Group, Inc. (SLS) files a new round, hires execs, or shows traction signals.

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.